Workplace ban on sugary drinks plus brief counseling to reduce belly fat
Multi-Level Trial of a Workplace Sales Ban of Sugary Beverages and Brief Motivational Counseling Intervention on Adiposity
This project tries a workplace sugary-drink sales ban together with short motivational counseling to help working adults lower belly fat and weight and reduce diabetes risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11296867 on NIH RePORTER |
What this research studies
At 16 hospital campuses in Northern California, some sites will stop selling sugary beverages while others keep usual drink options. Employees at those campuses will be randomized to receive brief one-on-one motivational counseling aimed at cutting sugary-drink use or to usual care. About 700 employees will be followed to see whether the combined policy and counseling reduce sugar-sweetened beverage consumption, cravings, and abdominal obesity. The study measures body fat, BMI, and related metabolic markers over the trial period to track changes.
Who could benefit from this research
Good fit: Working adults employed at participating hospital campuses, especially those with excess belly fat, overweight, or at risk for type 2 diabetes, are the intended participants.
Not a fit: People who do not work at the participating sites, children, or those who already avoid sugary drinks are unlikely to receive direct benefit from joining this trial.
Why it matters
Potential benefit: If successful, this approach could help employees lose abdominal fat, lower weight, and reduce risk factors for type 2 diabetes by cutting sugary-drink intake.
How similar studies have performed: Replacing sugary drinks in schools and brief counseling for other unhealthy habits have shown promise, but combining a workplace sales ban with counseling for sugary-drink reduction is relatively new.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Schmidt, Laura a — University of California, San Francisco
- Study coordinator: Schmidt, Laura a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.